Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
Brunner HI, Ruperto N, Ramanan AV, Horneff G, Minden K, Calvo Penades I, Alexeeva E, Cleary G, Stern SM, Kone-Paut I, Maldonado Velázquez MDR, Rabinovich CE, Remesal A, Silva CA, Nikishina I, Zucchetto M, Brockwell L, Gordon O, Nagel S, De Benedetti F; PRINTO and PRCSG investigators.
Brunner HI, et al. Among authors: stern sm.
Rheumatology (Oxford). 2024 Mar 29:keae180. doi: 10.1093/rheumatology/keae180. Online ahead of print.
Rheumatology (Oxford). 2024.
PMID: 38552315